Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indobufen. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114685346A reveals high-purity indobufen synthesis technology. Offers significant cost reduction and supply chain reliability for global API manufacturing partners seeking quality.
High-purity 2-(4-nitrophenyl) butyric acid via micro-channel reactor. Enhanced safety and supply reliability for pharma manufacturing.
Patent CN108546720B reveals a green lipase-catalyzed route for Indobufen intermediates, offering high optical purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN114085152A reveals a green, high-yield route for 2-(4-nitrophenyl)butyric acid, eliminating nitration isomers for cost-effective API manufacturing.
Patent CN110229075A reveals water-based reduction. High yield, low waste. Reliable supplier for pharma intermediates.